Medicine & Government

Brought the full power of American medicine and government to produce a safe and effective vaccine in record time.

Launched Operation Warp Speed to initiate an unprecedented drive to develop and make available an effective vaccine by January 2021.
Pfizer and Moderna developed two vaccines in just nine months, five times faster than the fastest prior vaccine development in American history.
Pfizer and Moderna’s vaccines are approximately 95 effective – far exceeding all expectations.
AstraZeneca and Johnson & Johnson also both have promising candidates in the final stage of clinical trials.
The vaccines will be administered within 24 hours of FDA-approval.
Made millions of vaccine doses available before the end of 2020, with hundreds of millions more to quickly follow.
FedEx and UPS will ship doses from warehouses directly to local pharmacies, hospitals, and healthcare providers.
Finalized a partnership with CVS and Walgreens to deliver vaccines directly to residents of nursing homes and long-term care facilities as soon as a state requests it, at no cost to America’s seniors.
Signed an executive order to ensure that the United States government prioritizes getting the vaccine to American citizens before sending it to other nations.
Provided approximately $13 billion to accelerate vaccine development and to manufacture all of the top candidates in advance.
Provided critical investments of $4.1 billion to Moderna to support the development, manufacturing, and distribution of their vaccines.
Moderna announced its vaccine is 95 percent effective and is pending FDA approval.
Provided Pfizer up to $1.95 billion to support the mass-manufacturing and nationwide distribution of their vaccine candidate.
Pfizer announced its vaccine is 95 percent effective and is pending FDA approval.
Provided approximately $1 billion to support the manufacturing and distribution of Johnson & Johnson’s vaccine candidate.
Johnson & Johnson’s vaccine candidate reached the final stage of clinical trials.
Made up to $1.2 billion available to support AstraZeneca’s vaccine candidate.
AstraZeneca’s vaccine candidate reached the final stage of clinical trials.
Made an agreement to support the large-scale manufacturing of Novavax’s vaccine candidate with 100 million doses expected.
Partnered with Sanofi and GSK to support large-scale manufacturing of a COVID-19 investigational vaccine.
Awarded $200 million in funding to support vaccine preparedness and plans for the immediate distribution and administration of vaccines.
Provided $31 million to Cytvia for vaccine-related consumable products.
Under the PREP Act, issued guidance authorizing qualified pharmacy technicians to administer vaccines.
Announced that McKesson Corporation will produce store, and distribute vaccine ancillary supply kits on behalf of the Strategic National Stockpile to help healthcare workers who will administer vaccines.
Announced partnership with large-chain, independent, and regional pharmacies to deliver vaccines.

Prioritized resources for the most vulnerable Americans, including nursing home residents.

Quickly established guidelines for nursing homes and expanded telehealth opportunities to protect vulnerable seniors.
Increased surveillance, oversight, and transparency of all 15,417 Medicare and Medicaid nursing homes by requiring them to report cases of COVID-19 to all residents, their families, and the Centers for Disease Control and Prevention (CDC).
Required that all nursing homes test staff regularly.
Launched an unprecedented national nursing home training curriculum to equip nursing home staff with the knowledge they need to stop the spread of COVID-19.
Delivered $81 million for increased inspections and funded 35,000 members of the Nation Guard to deliver critical supplies to every Medicare-certified nursing homes.
Deployed Federal Task Force Strike Teams to provide onsite technical assistance and education to nursing homes experiencing outbreaks.
Distributed tens of billions of dollars in Provider Relief Funds to protect nursing homes, long-term care facilities, safety-net hospitals, rural hospitals, and communities hardest hit by the virus.
Released 1.5 million N95 respirators from the Strategic National Stockpile for distribution to over 3,000 nursing home facilities.
Directed the White House Opportunity and Revitalization Council to refocus on underserved communities impacted by the coronavirus.
Required that testing results reported include data on race, gender, ethnicity, and ZIP code, to ensure that resources were directed to communities disproportionately harmed by the virus.
Ensured testing was offered at 95 percent of Federally Qualified Health Centers (FQHC), which serve over 29 million patients in 12,000 communities across the Nation.
Invested an unprecedented $8 billion in tribal communities.
Maintained safe access for Veterans to VA healthcare throughout the COVID-19 Pandemic and supported non-VA hospital systems and private and state-run nursing homes with VA clinical teams.
Signed legislation ensuring no reduction of VA education benefits under the GI Bill for online distance learning.

Supported Americans as they safely return to school and work.

Issued the Guidelines for Opening Up America Again, a detailed blueprint to help governors as they began reopening the country. Focused on protecting the most vulnerable and mitigating the risk of any resurgence, while restarting the economy and allowing Americans to safely return to their jobs.
Helped Americans return to work by providing extensive guidance on workplace-safety measures to protect against COVID-19, and investigating over 10,000 coronavirus-related complaints and referrals.
Provided over $31 billion to support elementary and secondary schools.
Distributed 125 million face masks to school districts.
Provided comprehensive guidelines to schools on how to protect and identify high-risk individuals, prevent the spread of COVID-19, and conduct safe in-person teaching.
Brought back the safe return of college athletics, including Big Ten and Pac-12 football.

Rescued the American economy with nearly $3.4 trillion in relief, the largest financial aid package in history.

Secured an initial $8.3 billion Coronavirus Preparedness and Response Act, supporting the development of treatments and vaccines, and to procure critical medical supplies and equipment.
Signed the $100 billion Families First Coronavirus Relief Act, guaranteeing free coronavirus testing, emergency paid sick leave and family leave, Medicaid funding, and food assistance.
Signed the $2.3 trillion Coronavirus Aid, Relief, and Economic Security (CARES) Act, providing unprecedented and immediate relief to American families, workers, and businesses.
Signed additional legislation providing nearly $900 billion in support for coronavirus emergency response and relief, including critically needed funds to continue the Paycheck Protection Program.
Signed the Paycheck Protection Program and Healthcare Enhancement Act, adding an additional $310 billion to replenish the program.
Delivered approximately 160 million relief payments to hardworking Americans.
Through the Paycheck Protection Program, approved over $525 billion in forgivable loans to more than 5.2 million small businesses, supporting more than 51 million American jobs.
The Treasury Department approved the establishment of the Money Market Mutual Fund Liquidity Facility to provide liquidity to the financial system.
The Treasury Department, working with the Federal Reserve, was able to leverage approximately $4 trillion in emergency lending facilities.
Signed an executive order extending expanded unemployment benefits.
Signed an executive order to temporarily suspend student loan payments, evictions, and collection of payroll taxes.
Small Business Administration expanded access to emergency economic assistance for small businesses, faith-based, and religious entities.
Protected jobs for American workers impacted by COVID-19 by temporarily suspending several job-related nonimmigrant visas, including H-1B’s, H-2B’s without a nexus to the food-supply chain, certain H-4’s, as well as L’s and certain J’s.